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Key points
 Reduced vitamin D receptor (VDR) expression prompts skeletal muscle atrophy.
 Atrophy occurs through catabolic processes, namely the induction of autophagy, while anabolism
remains unchanged.
 In response to VDR-knockdown mitochondrial function and related gene-set expression is
impaired.
 In vitro VDR knockdown induces myogenic dysregulation occurring through impaired
differentiation.
 These results highlight the autonomous role the VDR has within skeletal muscle mass regulation.
Abstract Vitamin D deficiency is estimated to affect ∼40% of the world’s population and has been
associated with impaired muscle maintenance. Vitamin D exerts its actions through the vitamin
D receptor (VDR), the expression of which was recently confirmed in skeletal muscle, and its
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down-regulation is linked to reduced muscle mass and functional decline. To identify potential
mechanisms underlyingmuscle atrophy, we studied the impact of VDR knockdown (KD) onmature
skeletal muscle in vivo, andmyogenic regulation in vitro in C2C12 cells. MaleWistar rats underwent
in vivo electrotransfer (IVE) to knock down the VDR in hind-limb tibialis anterior (TA) muscle
for 10 days. Comprehensive metabolic and physiological analysis was undertaken to define the
influence loss of the VDR on muscle fibre composition, protein synthesis, anabolic and catabolic
signalling, mitochondrial phenotype and gene expression. Finally, in vitro lentiviral transfection was
used to induce sustained VDR-KD in C2C12 cells to analyse myogenic regulation. Muscle VDR-KD
elicited atrophy through a reduction in total protein content, resulting in lower myofibre area.
Activation of autophagic processes was observed, with no effect upon muscle protein synthesis or
anabolic signalling. Furthermore, RNA-sequencing analysis identified systematic down-regulation
ofmultiplemitochondrial respiration-related protein and genesets. Finally, in vitroVDR-knockdown
impaired myogenesis (cell cycling, differentiation and myotube formation). Together, these data
indicate a fundamental regulatory role of the VDR in the regulation of myogenesis andmuscle mass,
whereby it acts to maintain muscle mitochondrial function and limit autophagy.
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Introduction
VitaminDdeficiency (25-hydroxyvitaminD<50 nmol/L)
is globally widespread, affecting ∼40% of all adults
(Forrest & Stuhldreher, 2011). The classical function of
vitamin D is to regulate calcium (Ca2+) and phosphate
(Pi) homeostasis to maintain bone health and prevent
rickets (Arthur W. Ham, 1934), osteomalacia (Bhan et al.
2010) and osteoporosis (Rizzoli et al. 2008). However,
vitamin D deficiency has also been linked to deterioration
of wider musculoskeletal health, including a reduction
in skeletal muscle mass/function (Dhanwal et al. 2013),
a higher risk of falls in old age (Bischoff-Ferrari et al.
2004b), and the exacerbation of cachexia (Dev et al. 2011)
and type 2 diabetes (Pittas et al. 2007). Furthermore,
chronic vitamin D deficiency in humans is accompanied
by signs of myopathy that can be rescued by vitamin D
supplementation (Prabhala et al. 2000). Similarly, vitamin
D supplementation has been shown to enhance muscle
function and myofibre cross-sectional area (CSA) in the
elderly (Sato et al. 2005; Ceglia et al. 2013) and in
athletes (Close et al. 2013;Wyon et al. 2016), although not
consistently (Halfon et al. 2015).Nonetheless, in summary,
there aremulti-faceted links between vitaminD status and
musculoskeletal health. This has led to efforts to elucidate
mechanistic links between vitamin D and muscle mass
and function.
Consistent with a pro-myogenic role of vitamin D,
exogenous vitamin D promoted the differentiation of
muscle cells in vitro (Okuno et al. 2012; Girgis et al.
2014a). Vitamin D exerts its genomic functions through
the ubiquitously expressed vitamin D receptor (VDR)
(Norman, 2008). Studies have confirmed expression
of the VDR (Pike, 2014) and CYP27B1 [inactive
25-hydroxyvitamin D3 > active 1α,25-dihydroxyvitamin
D3 (1α,25(OH)2D3)] in fully differentiated skeletal
muscle of both rodents and humans (Srikuea et al. 2012).
Exogenous vitamin D up-regulates VDR mRNA and
vitaminDmetabolism in skeletalmuscle (van derMeijden
et al. 2016). Furthermore, the VDR is required for vitamin
D-induced anti-proliferative, pro-differentiation effects
(Irazoqui et al. 2014), while acute VDR-knockdown
(KD) [i.e. small interfering RNA (siRNA)] silencing
results in impaired myogenic differentiation (Tanaka et al.
2014). However, acute siRNA of the VDR is inadequate
for the characterization of the role of VDR throughout
proliferation and terminal myogenesis. Nevertheless,
the available in vitro data are consistent with a role
of VDR expression in the regulation of skeletal muscle
metabolism, in the absence of themanipulation of vitamin
D bioavailability.
In vivo down-regulation of the VDR has been linked
to multiple muscle catabolic disease states, while its
transgenic deletion also induces muscle pathology. For
instance, clinical studies have shown that VDR expression
inmuscle decreases with age (Bischoff-Ferrari et al. 2004a;
M. Scimeca, F. Centofanti, M. Celi, E. Gasbarra, G.
Novelli, A. Botta, 2018), as have in vivo experiments, in
which whole-body VDR knockout (VDR-KO) mice have
been shown to exhibit reductions in muscle fibre size
and grip strength (Endo et al. 2003; Girgis et al. 2015).
Furthermore, aberrant expression of myogenic regulatory
factors (myf5 andmyogenin) has been shown in VDR-KO
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Table 1. shRNA oligonucleotide sequences
Name Sequence Source Identifier
Rat VDR shRNA 1 AATGGAGATTGCCGCATCACCAAGGACAA Origene TL709870
Rat VDR shRNA 2 TCACCTCCGATGACCAGATTGTCCTGCTT Origene TL709870
Rat VDR shRNA 3 GCTGGTGGAAGCCATTCAGGACCGCCTAT Origene TL709870
Rat VDR shRNA 4 TTGTGCTGGAGGTGTTCGGCAATGAGATC Origene TL709870
Rat scrambled shRNA GCACTACCAGAGCTAACTCAGATAGTACT Origene TR30021
muscle (Endo et al. 2003).However, whole-bodyVDR-KO
impacts Ca2+/Pi homeostasis and bone metabolism, such
that mice require a rescue diet to normalize bloodmineral
ion levels (Amling et al. 1999), which are notoriously
difficult to control. Thus, developmental dysregulation
and hypocalcaemia in VDR-KO models preclude the
identification of a post-natal role of the VDR in skeletal
muscle.
While regulation of skeletal muscle mass and myo-
genic development by the VDR has been suggested, the
mechanisms of this are ill-defined. Here, we report a
comprehensive study into the autonomous role of the
VDR in skeletal muscle. First, we demonstrate that a
reduction of function (knockdown) of the VDR in a
pre-clinical model in vivo results in myofibre atrophy
and an associated up-regulation of autophagy-related
transcriptional and post-transcriptional pathways, rather
than down-regulation of protein synthesis. Second, we
show that sustained in vitroVDR-KD impairs myogenesis
(proliferation and myotube development).
Materials and methods
Ethical approval
All animal experimental procedures were undertaken and
approved by the Royal Veterinary College’s Ethics and
Welfare committee and were carried out under UK Home
Office licence to comply with the Animals (Scientific
Procedures) Act 1986.
Animal handling
Eight-week-old male Wistar rats were housed at
22 ± 0.5°C under a 12 h day/12 h night cycle and
acclimatized to their new surroundings for 1 week.
Animals were provided with water and a standard
chow diet ad libitum (Special Diet Services, LBS
Biotechnology, London, UK) [contained cholecalciferol
(D3) at 621.7 IU/kg]. Seven rats underwent in vivo electro-
transfer (IVE), whereby after 10 days rats were fasted
overnight and killed by injection of pentobarbitone.
Muscles were rapidly dissected thereafter; transverse
sections were mounted on cork tiles in optimum cutting
temperature (OCT) medium and snap-frozen in liquid
nitrogen-cooled isopentane. The remaining muscle was
snap frozen by freeze-clamping and stored at −80°C.
In vivo electrotransfer
IVE procedures were undertaken as previously described
(Cleasby et al. 2007). Animals were operated upon under
surgical depth anaesthesia, induced andmaintained using
isofluorane (2.5%), and their hind limbs shaved and
prepared with ethanol. Tibialis anterior muscles received
six spaced intramuscular injections of 50 μl aliquots of
lenti shRNA particles prepared in endotoxin-free sterile
saline at 0.5 mg/ml. Each shRNA cassette contained a U6
promoter, the target hairpin and a termination sequence.
VDR-KD groups received VDR shRNA (Origene,
Rockville, MD, USA) (Table 1) into the right tibialis
muscle and scramble shRNA into the left tibialis muscle.
Immediately following this, one 900 V/cm, 100 μs pulse
and four 90 V/cm, 100 ms pulses were administered
across the distal limb via tweezer-electrodes attached to
an ECM-830 electroporator (BTX, Holliston, MA, USA).
Animals subsequently received a subcutaneous injection
of carprofen (50 mg/kg), before recovery and monitoring
from anaesthesia.
Cell culture
C2C12 murine myoblasts (passage 6−10, ECACC,
Salisbury, UK)were grown inDulbecco’s-modified Eagle’s
medium (DMEM, Invitrogen, Paisley, UK) supplemented
with 10% (v/v) heat-inactivated fetal bovine serum
(FBS, Sigma Aldrich, Poole, UK), penicillin (100 U/ml),
streptomycin (100 μg/ml), amphotericin B (250 ng/ml),
l-glutamine (2 mM; all Sigma-Aldrich) at 37°C in a 5%
CO2 atmosphere (growth media). Myoblasts were seeded
in six-well plates (Nunclon Delta; Thermo Scientific,
Loughborough, UK) and grown until ∼95% confluent
(2−3 days); differentiation was induced by switching to
medium containing 2% FBS (v/v) (differentiation media).
Mediumwas changed every 48 h; however, in experiments
in which signalling was assessed, medium was changed
24 h in advance to avoid associated acute perturbations.
© 2020 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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shRNA interference
The lentiviral plasmid used was based on pLKO.1
Clone ID: RMM3981-201757375 and targeted the
(3’ untranslated region) mouse sequence 5′-TTA
AATGTGATTGATCTCAGG-3′ of the mouse VDR
gene; a non-targeting scrambled (SCR) shRNA sequence
was used as a negative control, with the hairpin sequence
CCTAAGGTTAAGTCGCCCTCGCTCTAGCGAGGGC
GACTTAACCTTAGG (Addgene, Cambridge, MA,
USA). Oligonucleotides were obtained from ITDDNA
USA and suspended, annealed and cloned into pLKO.1
at the EcoRI and AgeI sites as per the pLKO.1 protocol
from Addgene. DH5α cells were transformed with
the resultant plasmids for amplification and isolation.
HEK293FT cells (Invitrogen, Carlsbad, CA, USA) were
grown in DMEM, the 80−85% confluent plates were
rinsed once with Opti-MEM (Invitrogen) and then
incubated with Opti-MEM for 4 h before transfections.
psPAX2 and pMD2.G, along with either scramble or
pLKO.1 clones targeting mouse VDR (three clones), were
added after mixing with Lipofectamine 2000, as per the
manufacturer’s instructions (Invitrogen). Opti-MEM
was changed after overnight incubation with DMEM
containing 10% FBS without antibiotics to allow cells
to take up the plasmids and recover. Culture media
was collected 36 and 72 h post-transfection to obtain
viral particles. The viral particles present in the super-
natant were harvested after 15 min of centrifugation at
1500 g to remove cellular debris. The supernatant was
further filtered using a 0.45μm syringe filter. Supernatant
containing virus was either stored at−80°C for long-term
storage or at 4°C for immediate use. C2C12 cells at 60%
confluencewere infected twice overnight with 3ml of viral
supernatant containing 8 μg/ml polybrene in serum-free,
antibiotic-free DMEM. Fresh DMEMmedium containing
10% FBS, antibiotics and 2 μg/ml puromycin (Sigma)
were added the next day. Cells that survived under
puromycin selection were either harvested as stable
clones and stored or studied following differentiation.
Cell counts and BrdU assay
Myoblasts were seeded in six-well plates and counted
by trypsinization of adherent cells into 1 ml DMEM.
Measurements weremade 96 h after seeding and each well
was counted in quadruplicate using a haemocytometer.
DNA synthesis of myoblasts was measured via the
incorporation of BrdU in place of thymidine, and
detected by a colorimetric ELISA assay (no. 6813, Cell
Signalling Technology, Danvers, MA, USA) following the
manufacturer’s recommendations. Cells were seeded in a
96-well plate (Nunclon Delta; Thermo Scientific) with the
addition of BrdU at a final 1× concentration 24 h before
measurement.
Cell cycle analysis
Myoblasts were seeded in six-well plates and allowed
to proliferate for 24 h before being synchronized to
G1/early S phase by incubation with 2 mmol/l hydro-
xyurea (Sigma-Aldrich) for 15 h. The cell cycle lock was
then released by changing themedium. After 12 h the cells
were collected by trypsinization and centrifuged, before
being re-suspended in PBS/1% FBS and fixed in ice cold
80% ethanol for at least 1 h. The cells were pelleted by
centrifugation at 300 g and the ethanol-decanted pellet
was washed in PBS. The cells were then incubated in
propidium iodide (PI) staining solution [0.1% Triton
X-100, 10μg/ml PI (Sigma-Aldrich), 100μg/ml RNase in
PBS) for 30min in the dark, before flow cytometry analysis
on a Coulter FC 500 device (Beckman Coulter).
Myotube morphology of cultured cells
The medium was aspirated from the differentiated cells
(Day 6) which were washed twice in 2 ml PBS before
fixation in 2 ml PBS and methanol/acetone (2:1:1) for
5 min at room temperature. Fluoroshield mounting
medium with DAPI (Sigma Aldrich) was applied to allow
visualization of myonuclei. Normal light and fluorescent
images were obtained and merged, and the myotube
diameters were then measured using ImageJ software
(National Institutes ofHealth, Frederick,MD,USA).Myo-
tubes were defined as cells containing three or more myo-
nuclei and measured at three equidistant points along
their length. Five random fields of view were chosen per
well from four wells, with five myotubes per view being
measured on blinded images. Myotubes were stained
with phalloidin (Life Technologies, Manchester, UK) after
fixing in a 1:5 dilution of 2% horse serum/PBS before
visualization.
Protein/DNA/RNA measurements
Total cellular alkaline soluble protein,DNAandRNAwere
analysed spectrophotometrically, as previously described
(Crossland et al. 2013). For rat muscle samples, frozen
whole muscle (∼10 mg) was desiccated under vacuum,
before the addition of 0.3 mol/l NaOH and homo-
genization in a bead beater. For cell culture experiments,
cells were scraped into 0.3 mol/l NaOH and incubated
at 37°C for 30 min before an aliquot was taken for the
measurement of total protein using a Nanodrop (Thermo
Scientific). Thereafter, 1 M perchloric acid (PCA) was
added to the remaining sample, which was incubated
at 4°C for 10 min, before centrifugation at 3000 g for
10 min, washing in 0.2 mol/l PCA, and collection of
the supernatant for RNA measurement. The resulting
pellet was incubated at 70°C for 1 h in 2 M PCA, before
centrifugation at 5000 g, washing in 2 M PCA, and
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collection of the supernatant forDNAmeasurement. RNA
and DNA were quantified by measuring the absorbances
at 260 and 275 nm, and 268 and 284 nm, respectively.
Measurement of muscle protein synthesis (MPS)
Cells. Measurements of MPS were made in differentiated
cells using the stable isotope tracer deuteriumoxide (D2O)
(Crossland et al. 2013). The medium was changed 24 h
before the addition of D2O (70 at.%) to an enrichment of
5%. Cells were incubated for 2 h under normal conditions,
then 1 ml of medium was collected and cells were scraped
into cold homogenization buffer [50 mM Tris·HCl (pH
7.4), 50 mM NaF, 10 mM β-glycerophosphate disodium
salt, 1 mM EDTA, 1 mM EGTA and 1 mM activated
Na3VO4].
Rats. Seven days after IVE, the animals were
administered a D2O bolus by oral gavage (7. 2 ml/kg,
70 at.%). For basal and maximal D2O body water
enrichment, two animals were killed prior to and 2 h
after oral gavage (respectively) and blood was collected
in pre-chilled tubes containing lithium heparin. These
were subsequently cold-centrifuged at 1750 g, and plasma
aliquots were frozen at −80°C. Ten days after IVE, the
animals were overnight fasted and killed, before blood
and muscle was collected.
Samples were prepared as previously described
(Wilkinson et al. 2014). Briefly, ∼50 mg of muscle was
homogenized in ice-cold homogenization buffer, before
continuous vortexing for 10 min, and centrifugation at
13,000 g for 5 min at 4°C. For cells, scraped lysates were
homogenized on ice, before centrifugation as previously
mentioned. Pellets were washed in 70% ethanol, before
being hydrolysed overnight at 110°C in 1 ml of 0.1 mol/l
HCl and 1 ml of H+ dowex resin.
The hydrolysed amino acids were eluted into 2 mol/l
NH4OH, then evaporated to dryness. The deuterium
labelling of protein-bound alanine was determined
though conversion to its tert-butyldimethysilyl derivative
and assessed by single ion monitoring (SIM) of m/z
260 and 261 by gas chromatography-mass spectrometry.
D2O precursor enrichment of both plasma and cell
culture medium was measured using a modified acetone
exchange method (Yang et al. 1998) that was previously
used to assess MPS in cell culture (Crossland et al. 2013).
Two microlitres of 10 M NaOH and 1 μl acetone were
added to 100 μl of sample medium and vortex-mixed
for 15 s, before incubation at room temperature for 24 h,
allowing the exchange of hydrogen atoms for deuterium.
Acetone was extracted into n-heptane and injected into
a gas chromatograph-mass spectrophotometer, and D2O
enrichment measured via SIM of m/z 58 and 59. For rats,
basal plasma samples were used to determine the natural
D2O enrichment, with maximal enrichment occurring
2 h after D2O ingestion and the final plasma sample
used to average temporal precursor enrichment . All
samples were referenced to a standard curve of known
D2O enrichments, and fractional synthetic rate (FSR) was
calculated using the following equation:
FSR (%/h) = [(MPEAla)] /[3.7 × (MPEMW) × t] × 100
where MPEAla represents protein bound alanine
enrichment, MPEMW represents precursor enrichment
and t signifies time in hours (Gasier et al. 2010); 3.7
represents the average number of deuteriums labelled in
the precursor alanine.
qRT-PCR
RNA from cultured cells and skeletal muscle was
extracted in TRizol reagent (Invitrogen 15596026)
and reverse transcribed using a High-Capacity cDNA
Reverse Transcription kit (Applied Biosystems 4368814).
Quantitative reverse transcriptase PCR (qRT-PCR) was
performed on a ViiA7 Real-Time PCR system (Life
Technologies) with SYBR Select Master Mix (Applied
Biosystems 4472908) and primers designed in-house
using Primer Express (Table 2). Quantification was
performed using the 2−CT method and normalized to
GAPDH.
Western blotting
To quantify signalling molecules, rat muscles were homo-
genized in ice-cold homogenization buffer using clean
sharp scissors. Samples were centrifuged at 11,000 g
for 10 min at 4°C, and the supernatant was removed
and quantified by a Nanodrop. Extraction of rat VDR
proteins required homogenization and preparation in a
hyperosmolar lysis buffer (HLB) [urea 6.7 M, glycerol
10%, Tris-HCl 10 mM, SDS 1%, DTT 1 mM, PMSF
1 mM, and Protease Inhibitor Cocktail tablet (Roche,
West Sussex, UK)], as previously described (Girgis et al.
2014b). Cell lysates were homogenized and centrifuged as
previously stated, before protein content was quantified
by a Nanodrop. All samples were diluted in homo-
genization buffer and Laemmli loading buffer to the same
concentration.
Samples were loaded onto Criterion XT Bis-Tris 12%
SDS-PAGE gels (Bio-Rad, Hemel Hempstead, UK) for
electrophoresis for 1 h at 200 V. Separated proteins were
transferred onto a PVDF membrane for 45 min at 100 V,
then blocked in 5% low-fat milk in Tris-buffered saline
and 0.1% Tween-20 (TBST) for 1 h at room temperature.
Membranes were then incubated at 4°C overnight in 5%
milk in TBST primary antibody solutions. Afterwards,
membranes were washed three times for 5 min with
© 2020 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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Table 2. qRT-PCR primers
Gene Accession number Primer sequence
Mouse
GAPDH NM_008084.3 F GGGAGCCAAAAGGGTCATCA
R TGATGGCATGGACTGTGGTC
VDR NM_009504.4 F GCTATTCTCCAAGGCCCACA
R CCGGTTCCATCATGTCCAGT
Rat
GAPDH NM_017008.4 F ATCCCGCTAACATCAAATGG
R GTGGTTCACACCCATCACAA
VDR NM_017058.1 F GGTTTCTTCAGGCGGAGCAT
R GGTGATGCGGCAATCTCCAT
Trim63 (Murf1) NM_080903.1 F CACCTTCCTCTTGAGTGCCA
R CTCAAGGCCTCTGCTATGTGT
Fbxo32 (Atrogin-1) NM_133521.1 F AGCTTGTGCGATGTTACCCA
R GGTGAAAGTGAGACGGAGCA
Fbxo40 XM_006248404.3 F CGGGGTTGGCATAAGTGCTA
R CAGAGGACCCGAGTTGACTTC
PSMD11 NM_001107027.1 F CGACCCAATCATCAGCACAC
R GGCCTCTTACCAGACAGACAG
ATG5 NM_001014250.1 F CAGAAGCTGTTCCGTCCTGT
R CCGTGAATCATCACCTGGCT
ATG7 NM_001012097.1 F CAGCCTGTTCATCCAAAGTTCTTG
R CTGTGGTTGCTCAGACGGT
Ctsl NM_013156.2 F CTATCGCCACCAGAAGCACA
R ACCACACTGGCCCTGATTCT
Casp3 NM_012922.2 F CGGACCTGTGGACCTGAAAA
R CGGCCTCCACTGGTATCTTC
Capn2 NM_017116.2 F TCGGCATCTATGAGGTCCCA
R ATTCTTGTGGGGCTCGAAGG
TBST and incubated for 1 h at room temperature
in their respective HRP-conjugated secondary anti-
body, anti-rabbit (Cell Signalling Technologies) 1:2000
5% low-fat milk in TBST, anti-mouse (Cell Signalling
Technologies) or 1:2000 5% low-fat milk in TBST.
Membranes were washed three times for 5 min in TBST,
incubated for 5 min in enhanced chemiluminescence
reagent (Millipore, Watford, UK) and visualized using a
Chemidoc XRS. Bands were quantified using ImageLab
software and normalized to total loaded protein visualized
byCoomassie brilliant blue or Ponceau staining (Bass et al.
2017).
Primary antibodies against p-AKT Ser473 (1:2000,
#4060), Pan-AKT (1:2000, #4685), p-TSC2 Thr1462
(1:2000, #3611), TSC2 (1:2000, #4308), p-mTOR Ser2448
(1:2000, #2976), mTOR (1:2000, #2972), p-p70S6K1
Thr389 (1:2000, #9234), p70S6K1 (1:2000, #2708),
p-S6RP Ser235/236 (1:2000, #2211), S6RP (1:2000,
#2217), p-4e-BP1 Thr37/46 (1:2000, #2855), 4e-BP1
(1:2000, #9644), p-eIF4E Ser209 (1:2000, #9741), eIF4E
(1:2000, #9742), Beclin 1 (1:2000, #3495), p-AMPK
Thr172 (1:2000, #2535), p-Raptor Ser792 (1:2000, #2083)
and LC3B (1:1000, #2775) were from Cell Signalling
Technologies. Primary antibody against Cathepsin L
(1:2000, Ab6314) was from Abcam (Cambridge, MA,
USA). Primary antibody against VDR (D-6) (1:2000,
SC-13133) was from Santa Cruz (Santa Cruz, CA, USA).
Mitochondrial complex expression was undertaken as
previously described (Ashcroft et al. 2020). MitoProfile
OXPHOS antibody cocktail (110413) was purchased from
Abcam and citrate synthase (SAB2701077) was from
Sigma Aldrich.
Immunofluorescence
Muscle cross-sections 5 μm thick were cut at −22°C
using a Cryostat, before mounting on glass slides and
air-drying at room temperature. Sections were fixed in
acetone/ethanol (3:1) for 5min, andwashed three times in
PBS. Fibre CSA and VDR expression analysis was under-
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taken at the University of Birmingham. For CSA analysis,
primary antibodies towards VDR (Rabbit, Ab109234,
Abcam) and dystrophin [Mouse, MANDYS1(3B7),
Developmental Studies Hybridoma Bank, Iowa City, IA,
USA] were diluted in 5% goat serum in PBS at 1:50 and
1:200, respectively. Antibody solutions were applied to
each section before incubation for 2 h in a humidity
chamber at room temperature, then washed in PBS three
times. Secondary fluorescent anti-rabbit (Alexa Fluor 594,
A11012, Invitrogen) and anti-mouse (Alexa Fluor 488,
A21121, Invitrogen) antibodies were diluted in PBS 1:200
and sections were incubated for 30 min as before. Slides
were then washed three times in PBS, and 1:1000 DAPI
stain (Invitrogen) was applied for 5 min before three PBS
washes. Mounting medium (Invitrogen) was applied to
each section and dried in darkness overnight. Additional
sections were probed using anti-MHC IIa (SC-71) or
anti-MHC IIb (BF-F3) diluted 1:50 in PBS. All sections
were imaged in a blinded fashion using a Nikon Eclipse
E600 and analysed using Image Pro3D capture software.
Three random fields of view were measured per section.
RNA-sequencing analysis
RNA was extracted from snap-frozen muscle using
an RNeasy mini kit (Qiagen, Valencia, CA, USA),
following the manufacturer’s recommendations. All RNA
samples had RNA integrity number (RIN) (Schroeder
et al. 2006) scores of greater than 8. RNA was pre-
pared using the Tru-Seq RNA library preparation kit
(Illumina) and RNA-sequencing (RNA-seq) was carried
out by Edinburgh Genomics using the Illumina HiSeq
4000 platform, which generated 75 bp paired-end reads.
Following quality control and base-calling, tag data were
examined with Fast QC and adaptor sequences were
trimmed where necessary using Trimmomatic (Bolger
et al. 2014; Andrews, 2016). Unpaired reads were found
to be of low quality and were dropped from the analysis,
with no set of paired reads failing quality control.
Alignment and feature counts were created using the
Rsubread package in R and the edgeR package to examine
differential expression (Robinson et al. 2010; Liao et al.
2013). The count data were filtered as recommended by
the authors of edgeR by identifying the CPM at a count
of 10 (Lun et al. 2016). Subsequent normalization was
with the trimmed mean of M-values method (Robinson
& Oshlack, 2010). Differential expression was analysed
using the glmFit function of edgeR with design matrices
to take account of biological pairing between treated and
control limbs. Subsequent geneset testing was carried out
using the GSEABase library (Morgan et al. 2017) in R,
using genesets from the Molecular Signatures Database,
maintained by the Broad Institute (Liberzon et al. 2011).
PathVisio v 3.3.0 (van Iersel et al. 2008; Kutmon et al.
2015) was used to construct all pathway analysis, with
pathways from the WikiPathways repository (Kutmon
et al. 2016). The Rattus norvegicus Derby Ensembl 91
database was used for the identity-mapping of genes,
with log fold changes (</>0.26) of each gene mapped
to pathway nodes and differently expressed genes were
visualized.
Statistical analysis
The results are displayed as mean ± SD. The primary
measure was the assessment of MPS, requiring a sample
size of n = 7 animals for paired contralateral design
(Power = 0.8, d = 1.64, α = 0.05). All analysis was
performed by an unpaired (or paired where appropriate)
t-test for two group comparisons or ANOVA with
Bonferroni or Tukey post hoc analysis between multiple
groups on GraphPad Prism7. A P value < 0.05 was
considered to represent statistical significance.
Results
In vivo VDR-KD induces skeletal muscle atrophy
To avoid the confounding effects of VDR-mediated
developmental and hypocalcaemia-related dysregulation
inherent to germline genetic manipulation, we modified
VDR expression in post-natal skeletal muscle. Employing
established IVE (Cleasby et al. 2005) of vectors expressing
Vdr shRNA (or scrambled sequences in the contra-
lateral limb, Fig. 1A), we confirmed Vdr knockdown
(VDR-KD) in rat tibialis anterior (TA) by qRT-PCR
Figure 1. In vivo experimental design
and grouping
A, schematic design of in vivo experiments. B,
confirmation of contralateral VDR-KD by
qRT-PCR (N = 7). C, representative western
blot and quantification of VDR-KD (N = 7).
Scale bars represent 200 μm. Data are
individual values with mean ± SD. Data were
analysed using paired t-tests. [Colour figure
can be viewed at wileyonlinelibrary.com]
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(VDR-KD: −59 ± 20%) and immunoblotting (VDR-KD:
−52 ± 29%) (Fig. 1B and C). Functional protein
suppression by IVE is persistent and acute inflammation
abates after 7 days in skeletal muscle (Cleasby et al.
2005). To determine the effects of VDR-KD on fibre
CSA, we immunostained fibres for dystrophin (Fig. 2A),
and showed that VDR-KD fibres were smaller (Fig. 2B)
than contralateral control limb myofibres. Because
tibialis muscle mainly consists of fast myosin isoforms,
cryosections were immunostained for myosin IIa and
IIb, which revealed marked reductions in type IIb fibre
CSA following VDR-KD (Fig. 2C and D). To verify
myofibre atrophy, we also quantified muscle alkaline
soluble protein (ASP) content and observed decreases
in VDR-KD muscles (Fig. 2E). Analyses of total RNA
and DNA content demonstrated no difference between
VDR-KD and control muscle (Fig. 2F and G).
Anabolic signalling is unaffected, whereas
autophagic processes are upregulated by VDR-KD
Because fibre atrophy can result from an impairment
in MPS, we quantified MPS using the stable isotope
tracer deuterium oxide (D2O) and found that global
(i.e. across multiple muscle fractions, including myo-
fibrillar, collagenous and sarcoplasmic) MPS rates were
not affected by VDR-KD (VDR-KD 13.2 ± 4%d vs.
Control 11.4 ± 2.7%d, Fig. 3A). Furthermore, neither
protein abundance nor activity (phosphorylation)
of indispensable muscle anabolic signalling pathways
(AKT/mTORc1) were significantly reduced (e.g. p-mTOR
VDR-KD 116 ± 78% vs. Control 100 ± 67%, Fig. 3B).
These results suggest that the VDR-KD-inducedmyofibre
atrophy and associated net loss of muscle protein were
not due to changes in MPS, but instead due to greater
proteolysis.
To determine whether fibre atrophy occurred through
an alteration in muscle protein breakdown (MPB), we
quantified the mRNA abundance of established markers
of proteolytic degradation (Sandri, 2013). We identified
activation of autophagy markers (e.g. Atg5, VDR-KD
183 ± 64% vs. Control 100 ± 54%, P = 0.035,
Atg7 VDR-KD 170 ± 68% vs. Control 100 ± 41%,
P= 0.018) and induction of caspase and calpain pathways
(Casp3 VDR-KD 181 ± 66% vs. Control 100 ± 46%,
P = 0.044, Fig. 3C). In contrast, there were no effects
Figure 2. In vivo VDR-KD results in muscle fibre atrophy
A, representative images of muscle fibres stained for dystrophin (green), DAPI (blue) and VDR (red). Scale bars
represent 200 μm. B, all fibre CSA analysis; C, Type IIa; and D, IIb fibre CSA distribution. Three random fields of
view were measured per section in both L and R TA muscles in each animal (N = 7), with CSA measured for all
intact fibres. E, alkaline soluble protein measures; F, RNA; and G, DNA quantification per mg dried muscle (n = 7).
Data are individual values with mean ± SD. Data were analysed using paired t-tests. [Colour figure can be viewed
at wileyonlinelibrary.com]
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on proteasomal systems (Fig. 3C). Additional immuno-
blotting for validated autophagy markers showed an
increase in protein abundance of both lysosomal enzymes
and upstream regulatory pathways in VDR-KD muscles
[Cathepsin L (CTSL) VDR-KD 172 ± 77% vs. Control
100 ± 28%, P = 0.031), light chain 3B-II (LC3B-II;
VDR-KD 183± 114% vs. Control 100± 47%, P< 0.045)]
and p-RAPTORSer792 (VDR-KD 162 ± 74% vs. Control
100 ± 43%, P = 0.022) (Fig. 3D).
RNA-seq analysis demonstrated that VDR-KD
up-regulates autophagic geneset and down-regulates
mitochondrial metabolic processes
To identify the changes in global regulatory genes
associated with the myofibre atrophy induced by
VDR-KD, we utilized RNA-seq of cDNA libraries
generated from VDR-KD muscles (GSE110507) and
contralateral scramble-transfected controls. VDR-KD
induced differential expression of 1000 genes (P < 0.05)
(Fig. 4A) and multiple genesets [n = 107, false discovery
rate (FDR) <5%] (Supplemental file 1). Notably,
geneset enrichment analysis revealed an upregulation
in key autophagy-related genesets: KEGG_lysosome
(P = 3.52E-05) and Reactome_Lysosome vesicle
biogenesis (P = 0.0002) (Fig. 4B). Interestingly,
there was also downregulation of numerous genesets
involved in energy metabolism: Reactome_Respiratory
electron transport (P = 3.29E-12), KEGG_Oxidative
phosphorylation (P= 5.70E-09), and Reactome_Pyruvate
metabolism and citric acid cycle TCAcycle (P= 3.48E-07)
(Fig. 4C). Additional pathway analysis revealed an
attenuation of electron transport chain (ETC) (Fig. 5A)
gene expression, which was matched by a reduction in
expression of mitochondrial ETC subunit complexes I
(VDR-KD 53 ± 30% vs. Control 100 ± 43%, P = 0.055)
and IV [VDR-KD 68 ± 26% fold change (FC) vs. Control
Figure 3. In vivo VDR-KD increases autophagy-related pathways
A, measurement of mixed lysate MPS rates by D2O incorporation (N = 7). B, quantification and representative
western blots of phosphorylated and total protein anabolic signalling intermediates (n = 7). C, qRT-PCR
measurement of proteolysis-related gene expression. D, quantification and representative western blots of
autophagy-related protein expression (n = 7). Data are individual values with mean ± SD. ∗P < 0.05, ∗∗P < 0.01
between the indicated groups. Data were analysed using paired t-tests. [Colour figure can be viewed at
wileyonlinelibrary.com]
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Figure 4. VDR-KD upregulates autophagy-related gene-sets whilst downregulating mitochondrial
metabolic processes
A, volcano plot of P < 0.05 statistically significant up-/downregulated genes. B, top five upregulated and down-
regulated gene-sets from the Molecular signatures database for VDR-OE muscles (n = 7). See also Supplemental
file 1. [Colour figure can be viewed at wileyonlinelibrary.com]
Figure 5. In vivo VDR-KD reduces electron transport chain-related gene expression
A, RNA-seq pathway analysis of Rattus norvegicus electron transport chain gene expression. Log fold changes
are shown as a gradient from red (upregulated) to blue (downregulated). B, quantification and representative
western blot analysis of individual mitochondrial electron transport chain complex protein expression (n = 7). Data
are individual values with mean ± SD. P values are for comparisons between the indicated groups. Data were
analysed using paired t-tests. [Colour figure can be viewed at wileyonlinelibrary.com]
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100 ± 0.31%, P = 0.056, Fig. 5B]. Further analysis of
transcription factor (TF) enrichment demonstrated
a marked downregulation of muscle development
TFs, including multiple myocyte enhancer factor-2
(Mef2)-related genesets (MEF2_02 P = 4.04E-06,
MEF2_03 P = 1.17E-05) (Supplemental file 2), which
is critical for the control of muscle differentiation.
In vitro VDR-KD reduces myoblast proliferation and
terminal differentiation
Given the large number of genes associated with myo-
genesis that were impacted by in vivo VDR-KD, we next
investigated whether VDR might have a pro-myogenic
role by generating C2C12murine cells harbouring shRNA
lentiviral VDR knockdown (Vdr, VDR-KD −95 ± 3% vs.
Control 100 ± 20%, P = 0.0001, Fig. 6A and B), with
the hypothesis that VDR-KD in vitro would impair myo-
genesis. Using flow cytometry and the fluorescent probe
PI (for nuclear staining), we found that larger numbers of
VDR-KD myoblasts were in the G0–G1 phase of the cell
cycle (VDR-KD 52.1 ± 9.5% vs. Control 47.4 ± 11.4%,
P= 0.038, Fig. 6C). Consistent with this, the total number
of VDR-KD myoblasts 96 h after seeding was lower
(VDR-KD 98 × 104 ± 0.14 × 104 cells vs. Control
118 × 104 ± 5.1 × 104 cells, P = 0.001, Fig. 6D), and
this was associated with a reduction in DNA synthesis
[BrdU incorporationVDR-KD73.1± 8.7%FC vs. Control
100 ± 17.5% FC, P = 0.0004, Fig. 6E) and thus attenuated
proliferation.
Next, we studied the impact of VDR-KD on terminal
differentiation and observed fewer VDR-KD myotubes
than scramble-infected myotubes (VDR-KD 18.2 ± 1
myotube FC vs. Control 24.6 ± 3 myotube, P = 0.007,
Fig. 7A and B). Surprisingly, the myotubes that did
differentiate were larger (VDR-KD 23.5 ± 0.6 μm vs.
Control 21.4 ± 1.2 μm, P = 0.034, Fig. 7C). Consistent
with an impairment of differentiation in VDR-KD myo-
tubes, we observed an increase in the number of myo-
nuclei (VDR-KD 24.5 ± 3.4 myonuclei vs. Control
9.6 ± 0.9 myonuclei, P = 0.0002, Fig. 7D), coupled
with sustained increases in DNA content, despite serum
depletion (DNAday 6, VDR-KD 20.9± 3.2μg vs. Control
15.4 ± 1.8 μg, P = 0.006, Fig. 7E). Moreover, protein
and RNA content were lower in VDR-KD myotubes on
days 2 and 4 (RNA day 4, VDR-KD 71.7 ± 11.5 μg
vs. Control 98.1 ± 11.1 μg, P = 0, Fig. 7E). This was
also reflected in a lack of myosin induction throughout
the differentiation of VDR-KD myotubes [Myosin day 6,
VDR-KD 0.45 ± 0.24 arbitrary units (AU) vs. Control
3.98 ± 1.37 AU, P < 0.0001, Fig. 7F]. Finally, myofibrillar
Figure 6. In vitro VDR-KD impairs
myoblast cell cycle regulation and
proliferation
A, qRT-PCR analysis of VDR-KD by shRNA
(n = 5). B, representative western blot and
quantification showing VDR-KD (n = 6). C,
cell cycle proportions of proliferating
myoblasts (n = 7). D, total cell populations
(n = 4). E, BrdU incorporation within
proliferating myoblasts (n = 10). Data are
individual values with mean ± SD, ∗P < 0.05.
Data were analysed using t-tests. [Colour
figure can be viewed at
wileyonlinelibrary.com]
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MPSwas lower inVDR-KDcells than in scramble controls
(VDR-KD 0.87 ± 0.14% h vs. Control 1.46 ± 0.10% h,
P< 0.0001, Fig. 7G). Together, these findings indicate that
a reduction in VDR expression negatively influencesmyo-
genic processes by impairing myoblast proliferation and
terminal differentiation.
Discussion
Although recent work has demonstrated impaired
regulation of skeletal muscle mass in the presence of
vitamin D deficiency or low VDR expression (Dhanwal
et al. 2013; Girgis et al. 2019), the function of the VDR in
relation to skeletal muscle mass regulation remained
poorly defined. Here, IVE transfection techniques
were used to achieve short-term but sustained muscle
VDR-KD in an internally controlled (i.e. contralateral
limb) model, which also overcame the confounders of
developmental dysregulation and dietary confounders
(Amling et al. 1999; Endo et al. 2003).Using a combination
of targeted and untargeted approaches, we show VDR
loss-of-function rapidly induces muscle atrophy, and
that this is specifically associated with an upregulation of
autophagic processes.
First, we found a reduction of function in the VDR in
vivo resulted in muscle atrophy at the level of individual
fibres, along with an explanatory decrease in protein
content. This is consistent with the findings of previous
studies which showed that deletion of the VDR results
in lower whole-body lean mass and function (Girgis
et al. 2019), which occurs secondary to myofibre atrophy
(Endo et al. 2003; Girgis et al. 2015). Muscle atrophy
may occur as a result of a reduction in MPS, an increase
in MPB or a combination of the two, culminating in a
negative net protein balance (Rudrappa et al. 2016). In the
present study, no reductions in mRNA translation-related
signalling (i.e. AKT/mTORc1) were observed, nor
were there detectable changes in mRNA translational
efficiency/capacity processes (i.e. ribosomal content or
directly quantified global/fraction-specific rates of MPS;
Brook et al. 2016). Collectively, these data demonstrate
that while the vitamin D/VDR augments AKT/mTORc1
signalling (Salles et al. 2013), no loss occurs during
acute VDR deficiency. Weaker anabolic signalling (via
RPS6 and P70S6K) has been observed in response
Figure 7. In vitro VDR-KD impairs myogenesis and differentiation
A, representative images of myotubes 5 days after differentiation, stained with phalloidin (red) and DAPI (blue).
B, quantification of myotube population (n = 4). C, myotube diameter quantification (n = 4). D, quantification of
the number of myonuclei per myotube (n = 4). E, total alkaline soluble protein, DNA and RNA content throughout
differentiation (n = 6). F, western blot analysis of myosin IIx expression throughout differentiation (n = 6). G,
myofibrillar protein synthesis rates 5 days after differentiation (n = 6). Scale bars represent 100 μm. For all
grouped plots non-pairwise comparisons were made using two-sided t-tests. For time-course measurements,
ANOVA with multiple comparison by Tukey analysis were used. Data are individual values with mean ± SD.
∗P < 0.05, ∗∗∗∗P < 0.0001 between the groups indicated. ††P < 0.01, †††P < 0.001 between VDR-KD and shRNA
controls at that time point; §P < 0.05, §§P < 0.01 versus the initial time point. [Colour figure can be viewed at
wileyonlinelibrary.com]
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to vitamin D deficiency (18 weeks) (Gogulothu et al.
2020); however, this is probably due to systemic chronic
responses to vitamin D deficiency. Interestingly, it was
previously proposed that vitamin D deficiency induces
muscle atrophy through greater proteasome-mediated
degradation (Bhat et al. 2013). However, we observed
no modulation of proteasomal pathways; instead, pre-
vious findings may be related to Ca2+ dysregulation, as
evidenced by the expression of proteasomal markers and
partial rescue of atrophy by Ca2+ supplementation (Bhat
et al. 2013).
In contrast, targeted measurement of proteolytic
markers in VDR-KD muscle indicated an induction of
autophagosome formation (phosphorylated AMPK; Kim
et al. 2011), in addition to an upregulation of lysosomal
enzymes (at the mRNA and protein level). Crucially,
there were increases in the expression of Beclin 1 and
LC3B-II, vital contributors to autophagosome formation,
which demonstrates active autophagy induction (Wu
et al. 2006). A role for the vitamin D-VDR axis in the
regulation of autophagy has been previously reported.
Incubation of vitamin D with neurones, macrophages
and MCF-7 cells induces autophagy, while basal levels
of autophagy are much higher in VDR-KO MCF-7
cells and mouse mammary glands (Yuk et al. 2009;
Tavera-Mendoza et al. 2017), which suggests that LC3B
is constitutively repressed by the VDR (Tavera-Mendoza
et al. 2017). Vitamin D and subsequent VDR induction
attenuates the dysfunction of autophagy that occurs in
response to traumatic brain injury (Cui et al. 2017).
Moreover, IL6/STAT3, which are essential regulators of
autophagy, are upregulated in atrophied VDR-KOmuscle,
and this is partially rescued through STAT3 inhibition
(Gopinath, 2017). Recent investigations have suggested
direct VDR induction of IL6 and STAT3 phosphorylation
in dendritic cells (Català-Moll et al. 2020), which further
suggests a key role for the VDR in autophagy regulation.
The present findings extend this to skeletal muscle and
illustrate that in vivo ablation of the VDRmay not actively
induce autophagy; rather, its expression is inhibitory,
preventing muscle protein degradation. Consistent
with preliminary findings, follow-up global RNA-seq
analysis demonstrated upregulation of established muscle
atrophy-related genesets (lysosomal, including vesicle
biogenesis and NF-kappaB signalling) (Jackman et al.
2013). Furthermore, VDR is a well-established TF, and
ChIP-Seq datasets indicate that it has wide effects on
gene expression (Satoh & Tabunoki, 2013) and regulates
autophagy-related genes. These data build on and help
to explain previous observations that genetic loss of
the VDR results in a reduction in fibre size (through
poorly defined mechanisms; Endo et al. 2003; Girgis
et al. 2015), and perhaps the clinical links between
differences in VDR expression and muscle atrophy in
disease (Bischoff-Ferrari et al. 2004a; Punzi et al. 2012).
Indeed, in agreement with our findings, it has been
suggested that VDR-KO-mediated atrophy may occur
through unexplained reductions in protein content, rather
than necrosis (i.e. protein degradation, not apoptosis)
(Endo et al. 2003).
Analysis of the RNA-seq data revealed
down-regulation of numerous mitochondrial and
energy metabolism-related processes that have not
previously been described in response to VDR-KD.
Consistent with this, TF analysis of the RNA-seq data
revealed that MEF2 TFs, which are essential for ATP
production, complex I activity (She et al. 2011), and
the maintenance of mitochondrial integrity and gene
expression (e.g. PGC1-α) (Naya et al. 2002), were
markedly down-regulated by VDR-KD, which implies
that VDR is required for normal mitochondrial function.
The importance of VDR expression has previously
been suggested in other cell types: its expression has
been shown to be vital in keratinocytes, MCF-7 cells
and fibroblasts for normal mitochondrial regulation
(Ricca et al. 2018), and there is some evidence that it
may localize to the mitochondria (Silvagno et al. 2010).
Indeed, cultured myoblasts exhibit lower mitochondrial
respiration in response to VDR-KD, potentially through
impaired mitochondrial organization, membrane
permeability or calcium handling (Ashcroft et al.
2020), which implies that VDR is required for normal
mitochondrial function in skeletal muscle. Interestingly,
vitamin D may have additional regulatory functions.
Recent work (Ryan et al. 2016) has demonstrated that
the incubation of skeletal muscle cells with vitamin
D increases mitochondrial oxygen consumption and
fusion/fission dynamics, with ∼2000 associated mRNA
gene expression changes that are dependent upon the
VDR. Furthermore, vitamin D appears to have a physio-
logical role, because supplementation in humans reduces
muscle phosphocreatine recovery time (Sinha et al. 2013),
which is an established index of mitochondrial oxidative
capacity (Arnold et al. 1984). Here, the downregulation of
multiple mitochondrial/TCA cycle genesets by VDR-KD
reaffirms that the VDR is required for the maintenance of
mitochondrial energetics (Ricca et al. 2018) and highlights
it as a potential therapeutic target. It may also be that the
maintenance of mitochondria is upstream of muscle mass
preservation (Romanello & Sandri, 2016; Coen et al.
2019).
Given the putative role of the VDR in myogenesis,
we investigated the potential mechanisms further by
developing a sustained VDR-KD system in vitro, to study
the impacts on proliferation and differentiation in skeletal
muscle cells, somewhat reflecting the processes involved
in development, although our short-term post-natal in
vivo approach was designed not to capture these. Vitamin
D administration provokes G0–G1 cell cycle arrest,
with induction of cyclin D3, p21 and p27, which are
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important regulators of cell cycle withdrawal (Irazoqui
et al. 2014). Moreover, it has been demonstrated that they
are induced by VDR-dependent genomic mechanisms
(Irazoqui et al. 2014), with p21 being a vitamin D-target
gene, containing a VDR promoter region binding site
(Liu et al. 1996). Our findings extend and help to explain
these observations, revealing the VDR is required for
both cell cycle progression (G0–G1 transition) and trans-
ition to differentiation. Importantly, MPS in established
muscles remain unchanged (i.e. in vivo), demonstrating
the decreased in vitro MPS is due to lack of myo-
sin induction, highlighting the VDR requirement for
successful differentiation and development of muscle
fibres. Indeed, this clarifies why muscle developmental
dysregulation occurs in in vivo VDR-KO models prior to
study, which preclude the physiological characterization
of a post-natal role of the VDR (Endo et al. 2003; Girgis
et al. 2019). This may be evidenced by the lack of overall
differentiation in VDR-KD cells (reflecting ongoing DNA
synthesis) and the creation of very few, large myotubes. In
contrast, mature skeletal muscle is post-mitotic and has
limited capacity for satellite cell DNA synthesis (Drake
et al. 2015). Previous in vitro studies have demonstrated
that exogenous vitamin D positively mediates myofibre
hypertrophy (Salles et al. 2013) and increases myosin
expression (Garcia et al. 2011; van derMeijden et al. 2016)
in a VDR-dependent fashion (Buitrago et al. 2013). Thus,
concordant suppression of myofibrillar MPS and a lack of
myosin induction in VDR-KD myotubes may explain the
reductions inmusclemass and fibre size inVDR-nullmice
(Endo et al. 2003; Girgis et al. 2015), highlighting the key
autonomous role of the VDR in myoblast differentiation,
which does not require vitamin D stimulation.
Finally, it is important to note the limitations of this
investigation.While these data demonstrate robustmuscle
fibre atrophy 10 days after IVE, earlier measures would
allow for temporal CSA comparisons to be made. This
would clarify whether VDR-KD-induced fibre atrophy
was as a result of an arrest in fibre growth or overall
reduction in CSA. Similarly, later measures (i.e.>10 days)
may have permitted reductions in gene expression to
manifest in protein expression. Furthermore, we did not
directly measure the impact VDR-KD would have upon
muscle function (i.e. strength). Moreover, while anabolic
signalling remained unchanged, loss of the VDR may
impact stimulation of these pathways by exercise or diet.
Future studies may be able to clarify such responses and
whether a reduction in VDR expression (as seen in aged
muscle) may impair muscle mass gains.
Conclusion
The current study establishes an autonomous role
of the VDR in skeletal muscle mass regulation, with
lower expression eliciting myofibre atrophy through an
induction of autophagy-related pathways, and myogenic
dysregulation. Furthermore, theVDRplays a fundamental
modulatory role in skeletal muscle mitochondrial
function. These data suggest that modulation of VDR
expression or VDR-targeting therapies may positively
regulate skeletal muscle mass.
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